BDAI
Hitek Global Inc.
There isn't enough reported data to score BDAI yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
BDAI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
BDAI's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
BDAI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 94x | $1.87 | — |
| Cheap | 96x | $1.93 | +3.1% |
| Fair | 120x | $2.40 | +29% |
| Expensive | 134x | $2.68 | +44% |
Historical ranges are pointers, not guarantees.
BDAI's PE is 94x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over BDAI in the historical PE scenario, which offers more potential upside but is not a forecast.
BDAI Forward outlook
There aren't enough analyst estimates for BDAI to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
BDAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.02 | +$0.06 |
| Q2 2025 | -$0.08 | -300% |
| Q4 2024 | -$0.04 | -150% |
| Q4 2021 | $0.15 | 0% |
| Q4 2020 | $0.15 | -17% |
BDAI's earnings per share have fallen from their peak: $0.02 over the past year, against $0.18 in late 2019.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over BDAI in the latest year-over-year earnings comparison.
BDAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $5.8M | +441% |
| Q2 2025 | $741.5K | -60% |
| Q4 2024 | $1.1M | -34% |
| Q2 2024 | $1.8M | -38% |
| Q4 2023 | $1.6M | -55% |
| Q2 2023 | $2.9M | +3.1% |
| Q4 2022 | $3.6M | -45% |
| Q4 2021 | $6.5M | +11% |
BDAI has the edge over NVDA in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -7.7% | +18 points |
| Q2 2025 | -182% | -199 points |
| Q4 2024 | -128% | -153 points |
| Q2 2024 | -20% | -47 points |
| Q4 2023 | -25% | -58 points |
| Q2 2023 | 17% | -13 points |
| Q4 2022 | 24% | -7.4 points |
| Q2 2022 | 27% | -9.4 points |
BDAI's operating margin was −7.7% last quarter, up 18 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA's revenue has grown year over year for 13 quarters in a row: $96.2B last quarter, up 106% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA's operating margin was 66% last quarter, up 5.4 points from the same quarter a year ago, near the top of its range since 2019.
BDAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2024 | $744.3K | +1134% |
| Q4 2023 | -$308.7K | +$89.5K |
| Q2 2023 | $60.3K | -99% |
| Q4 2018 | $209.1K | -29% |
| Q2 2018 | -$302.6K | -$182.8K |
| Q4 2017 | $295.5K | +573% |
| Q2 2017 | -$119.8K | -$83.7K |
BDAI still generates free cash flow, though less than at its 2022 peak: $97,583 over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
BDAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +104% | +14.9M shares |
| 1 year | +234859% | +29.3M shares |
| 3 years | +333226% | +29.3M shares |
BDAI has 29M diluted shares, up 234859% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q2 2022 | — |
| Q4 2018 | — |
| Q2 2018 | — |
| Q4 2017 | — |
| Q2 2017 | — |
| Q4 2016 | — |
| Q2 2016 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over BDAI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
BDAI Net Leverage
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BDAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 13.8 | Oversold |
| Stochastic | 15.5 | Oversold |
BDAI's weekly RSI is 14 (oversold) and its Stochastic is 15 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
BDAI PE vs Technology Sector
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
BDAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.31 | 19% below |
| 20 week MA | $2.84 | 34% below |
NVDA has stronger trend alignment. BDAI is above 0 of 2 weekly averages versus NVDA above 1 of 5.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
BDAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $53.3 | $1.87 | -96% |
It's down 96% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over BDAI on returns for 2026, with the stronger performance.